Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Liu

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|June 9, 2025
The research of dapagliflozin on cognitive function in middle-aged and older patients with type 2 diabetes mellitus and mild cognitive impairment: a 36-week prospective parallel control studyJingcheng Ding, Liwei Zou, Runhe Xu, et al.
Diabetes, Obesity & Metabolism|August 5, 2025
Iodine uptake variability as a predictive biomarker for radioiodine therapy outcomes in Graves Disease: Validation through multi-time-point RAIU assessment in a 1249-patient cohortYifan Li, Meiwen He, Zilong Hu, et al.
Biochemistry|August 12, 2011
Mechanism of the intramolecular Claisen condensation reaction catalyzed by MenB, a crotonase superfamily memberHuei-Jiun Li, Xiaokai Li, Nina Liu, et al.
Analytical Biochemistry|February 17, 2015
A [(32)P]NAD(+)-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitorsWeixuan Yu, Carla Neckles, Andrew Chang, et al.
Structure (London, England : 1993)|January 17, 2012
Structure of the Yersinia pestis FabV enoyl-ACP reductase and its interaction with two 2-pyridone inhibitorsMaria W Hirschbeck, Jochen Kuper, Hao Lu, et al.
ACS Medicinal Chemistry Letters|January 24, 2012
CoA Adducts of 4-Oxo-4-Phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis PathwayXiaokai Li, Nina Liu, Huaning Zhang, et al.
ACS Chemical Biology|February 18, 2014
A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhAHuei-Jiun Li, Cheng-Tsung Lai, Pan Pan, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|February 22, 2023
Medical Disruptions During Center-Based Cardiac Rehabilitation: A Necessary Appraisal for the Development of Emerging Remote and Virtual Care ModelsAnthony Khong, Nina Liu, Shaun Giancaterino, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosisLaurent Bonnac, Guang-Yao Gao, Liqiang Chen, et al.
Journal of Pharmaceutical Sciences|January 18, 2025
Comparative analysis of empty and full adeno-associated viruses under stress conditions by anion-exchange chromatography, analytical ultracentrifugation, and mass photometryJulia A Townsend, Shuai Li, Laura Sweezy, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|June 9, 2025
The research of dapagliflozin on cognitive function in middle-aged and older patients with type 2 diabetes mellitus and mild cognitive impairment: a 36-week prospective parallel control studyJingcheng Ding, Liwei Zou, Runhe Xu, et al.
Diabetes, Obesity & Metabolism|August 5, 2025
Iodine uptake variability as a predictive biomarker for radioiodine therapy outcomes in Graves Disease: Validation through multi-time-point RAIU assessment in a 1249-patient cohortYifan Li, Meiwen He, Zilong Hu, et al.
Biochemistry|August 12, 2011
Mechanism of the intramolecular Claisen condensation reaction catalyzed by MenB, a crotonase superfamily memberHuei-Jiun Li, Xiaokai Li, Nina Liu, et al.
Analytical Biochemistry|February 17, 2015
A [(32)P]NAD(+)-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitorsWeixuan Yu, Carla Neckles, Andrew Chang, et al.
Structure (London, England : 1993)|January 17, 2012
Structure of the Yersinia pestis FabV enoyl-ACP reductase and its interaction with two 2-pyridone inhibitorsMaria W Hirschbeck, Jochen Kuper, Hao Lu, et al.
ACS Medicinal Chemistry Letters|January 24, 2012
CoA Adducts of 4-Oxo-4-Phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis PathwayXiaokai Li, Nina Liu, Huaning Zhang, et al.
ACS Chemical Biology|February 18, 2014
A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhAHuei-Jiun Li, Cheng-Tsung Lai, Pan Pan, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|February 22, 2023
Medical Disruptions During Center-Based Cardiac Rehabilitation: A Necessary Appraisal for the Development of Emerging Remote and Virtual Care ModelsAnthony Khong, Nina Liu, Shaun Giancaterino, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosisLaurent Bonnac, Guang-Yao Gao, Liqiang Chen, et al.
Journal of Pharmaceutical Sciences|January 18, 2025
Comparative analysis of empty and full adeno-associated viruses under stress conditions by anion-exchange chromatography, analytical ultracentrifugation, and mass photometryJulia A Townsend, Shuai Li, Laura Sweezy, et al.
Pageof 7